Yeah, let’s let 2,000 more people die tomorrow while we wait on Govbureauc lab coats to “approve”.
You’re right. It should be a lot less than 2,000 people dying each day. If only we had a competent president …
Regardless. 2000 people will die tomorrow even if they start administering a vaccine.
Although I do appreciate your sense of urgency.
TDS
And every day we aren’t sticking people. Weak assed excuse.
“We have to be surrrrre!”
No we ■■■■■■■ don’t. Get on with it.
1 Like
Yes of course. TDS. Acknowledging what an absolute failure Trumps response to COVID was is TDS. What a convenient crutch for you.
Trump is the only reason a vaccine is even a topic today and you know it.
As for the rest of your narrative:
Just to be clear. You think it’s in the best interest of the American people to skip FDA approval of the vaccine?
I know it is in the best interest of the citizens of this country for the FDA to approve the vaccines tonight.
His response was disastrous to the tune of 250,000 dead. It’s the reason he’s out of a job. When pressed to lead in times of crisis, he utterly failed. And we all are suffering because of it.
Ignore the facts. Stick to the narrative.
1 Like
So government approval is a good thing, it just takes too long?
It’s a necessary thing by law. Of course it takes too long.
Trump is a failure. He tricked people into thinking he could do this job. He failed. We are paying the price.
By no measure other than the election loss is he a failure.
You have a link to the facts.
1 Like
I hate to say it but I have more faith in Pfizer’s dividend than I do whatever is left of trump’s FDA.
From your own link:
On Monday, the New York Times published a report quoting Pfizer head of vaccine research and development Dr. Kathrin Jansen as saying, “We were never part of the Warp Speed … We have never taken any money from the U.S. government or from anyone.”
Though it is true that Pfizer did not take cash from the federal government to develop its vaccine, the company has entered into a $1.95 billion deal with the Trump administration to sell the government 100 million doses of its vaccine if completed by the end of the year.
Pfizer didn’t take any funds from the government to develop the vaccine, distribution of a product once created is a whole different animal.
.
.
.
.WW, PSHS
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to meet the U.S. government’s Operation Warp Speed program goal to begin delivering 300 million doses of a vaccine for COVID-19 in 2021. Under the agreement, the U.S. government will receive 100 million doses of BNT162, the COVID-19 vaccine candidate jointly developed by Pfizer and BioNTech, after Pfizer successfully manufactures and obtains approval or emergency use authorization from U.S. Food and Drug Administration (FDA).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005438/en/
The U.S. government will pay the companies $1.95 billion upon the receipt of the first 100 million doses, following FDA authorization or approval. The U.S. government also can acquire up to an additional 500 million doses.
As NPR reported in July, the government reached a deal for nearly two billion dollars to help distribute the vaccine. Pfizer’s own press release in July announced that the U.S. government placed an initial order of 100 million doses for $1.95 billion. No money went specifically into the vaccine’s research and development, but Pfizer absolutely did take government money, and was forced to walk back Jansen’s statement.
2 Likes
Pfizer was part of Warp Speed, the incentive waa just different.
Good news on the Pfizer front. While their needs for transport are different from Moderna in regards to temperatures needed, that doesn’t really pose a problem. Just make sure Pfizer stays urban, where more of these freezers are, and Moderna or possibly J&J or AZ shipped to more rural locations, where they aren’t as obtainable.
Since all of these vaccines are based on mRNA technology, the remaining vaccines should also provide equivalent efficacy, and that should definitely help ramp up rapid vaccination numbers.
3 Likes
